CrowdStrike reiterated its long-term ambition, which continues to anchor the model: reaching $10 billion in subscription ARR by fiscal 2031. Framed against today's run rate, this target assumes the ...
Acadia Pharmaceuticals Inc. was downgraded after a drug setback, but strong sales and a robust pipeline offer investment ...
Q4 2025 Earnings Call Transcript September 23, 2025 Operator: Greetings. Welcome to the Aytu BioPharma, Inc. report for ...
FEO VANCOUVER, BC, Sept. 25, 2025 /CNW/ – Oceanic Iron Ore Corp. (TSXV: FEO) (“Oceanic”, or the “Company”) is pleased to ...
During year 6 of continuous treatment with BRIUMVI the annualized relapse rate was 0.012, equivalent to one relapse occurring every 83 years of patient treatment Overall safety profile of BRIUMVI rema ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback